Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

A clinical trial has been conducted to evaluate the effect on vision of laser treatment (argon green or krypton red lasers, assigned randomly) compared with no treatment of eyes with subfoveal choroidal neovascularization associated with age-related macular degeneration. Three months after enrollment, the visual acuity of 37 (20%) of 184 laser-treated eyes had decreased 6 or more lines from the baseline level, while only 19 (11%) of 178 untreated eyes had suffered such large decreases (P = .01, chi 2 test). However, 24 months after enrollment, the visual acuity of only 23 (20%) of 114 laser-treated eyes had decreased by 6 or more lines from baseline compared with 41 (37%) of 112 untreated eyes (P less than .01, chi 2 test). On average, after 24 months, visual acuity of laser-treated eyes had decreased 3 lines from baseline, and visual acuity of untreated eyes had decreased 4 lines (P = .003, t test). Laser-treated eyes retained contrast threshold for large letters at or near baseline levels through 36 months of follow-up examinations, while the contrast threshold of untreated eyes worsened. Persistent or recurrent neovascularization was observed in 51% of the laser-treated eyes by 24 months after initial treatment but was not associated with decreased visual acuity. None of the findings suggested a reason to favor either the argon green or krypton red wavelength. Laser treatment of subfoveal neovascular lesions that meet the eligibility criteria for this study is recommended if both the patient and the ophthalmologist are prepared for a large decrease in visual acuity immediately after treatment.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Autologous Transplantation of RPE with Partial-Thickness Choroid after Mechanical Debridement of Bruch Membrane in the Rabbit
Hu et al.
IOVS 2008;49:3185-3192.
ABSTRACT | FULL TEXT  

Quantitative Subanalysis of Optical Coherence Tomography after Treatment with Ranibizumab for Neovascular Age-Related Macular Degeneration
Keane et al.
IOVS 2008;49:3115-3120.
ABSTRACT | FULL TEXT  

Recurrence of choroidal neovascularisation after photodynamic therapy in patients with age-related macular degeneration
Potter and Szabo
Br. J. Ophthalmol. 2007;91:753-756.
ABSTRACT | FULL TEXT  

Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation Study.
Costa et al.
IOVS 2006;47:4569-4578.
ABSTRACT | FULL TEXT  

Increased Glutathione Synthesis through an ARE-Nrf2-Dependent Pathway by Zinc in the RPE: Implication for Protection against Oxidative Stress.
Ha et al.
IOVS 2006;47:2709-2715.
ABSTRACT | FULL TEXT  

Lesion morphology in age-related macular degeneration and its therapeutic significance.
Beaumont and Kang
Arch Ophthalmol 2006;124:807-812.
ABSTRACT | FULL TEXT  

Iris Pigment Epithelial Translocation in the Treatment of Exudative Macular Degeneration: A 3-Year Follow-up.
Aisenbrey et al.
Arch Ophthalmol 2006;124:183-188.
ABSTRACT | FULL TEXT  

Which treatment is best for which AMD patient?
Kroll and Meyer
Br. J. Ophthalmol. 2006;90:128-130.
FULL TEXT  

Nonhuman Primate Models for Diabetic Ocular Neovascularization Using AAV2-Mediated Overexpression of Vascular Endothelial Growth Factor
Lebherz et al.
Diabetes 2005;54:1141-1149.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin: Observations on the Introduction of a New Treatment Into Clinical Practice
Schein et al.
Arch Ophthalmol 2005;123:58-63.
ABSTRACT | FULL TEXT  

Health- and Vision-Related Quality of Life Among Patients With Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery: Submacular Surgery Trials Report No. 5
Submacular Surgery Trials Research Group
Arch Ophthalmol 2005;123:78-88.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1597-1611.
ABSTRACT | FULL TEXT  

Reengineering of Aged Bruch's Membrane to Enhance Retinal Pigment Epithelium Repopulation
Tezel et al.
IOVS 2004;45:3337-3348.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of an Effectiveness Study
Sharma et al.
Arch Ophthalmol 2004;122:853-856.
ABSTRACT | FULL TEXT  

Prevalence of Age-Related Macular Degeneration in the United States
The Eye Diseases Prevalence Research Group
Arch Ophthalmol 2004;122:564-572.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin in Subfoveal Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy
Ergun et al.
Arch Ophthalmol 2004;122:37-41.
ABSTRACT | FULL TEXT  

Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes
van Meurs et al.
Br. J. Ophthalmol. 2004;88:110-113.
ABSTRACT | FULL TEXT  

Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study
Finger et al.
Br. J. Ophthalmol. 2003;87:1497-1503.
ABSTRACT | FULL TEXT  

Use of Best and Final Visual Acuity Outcomes in Ophthalmological Research
DiLoreto et al.
Arch Ophthalmol 2003;121:1586-1590.
ABSTRACT | FULL TEXT  

The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion
Cahill et al.
Br. J. Ophthalmol. 2003;87:1329-1332.
ABSTRACT | FULL TEXT  

Digital analysis of choroidal neovascularisation in consecutive fluorescein angiograms for use in longitudinal clinical trials
Bellmann et al.
Br. J. Ophthalmol. 2003;87:890-892.
ABSTRACT | FULL TEXT  

Large-Spot Size Transpupillary Thermotherapy for the Treatment of Occult Choroidal Neovascularization Associated With Age-Related Macular Degeneration
Thach et al.
Arch Ophthalmol 2003;121:817-820.
ABSTRACT | FULL TEXT  

A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration: One-Year Results
Gillies et al.
Arch Ophthalmol 2003;121:667-673.
ABSTRACT | FULL TEXT  

Responsiveness of the National Eye Institute Visual Function Questionnaire to Changes in Visual Acuity: Findings in Patients With Subfoveal Choroidal Neovascularization--SST Report No. 1
The Submacular Surgery Trials Research Group
Arch Ophthalmol 2003;121:531-539.
ABSTRACT | FULL TEXT  

Visual Outcomes Following Macular Translocation With 360{degrees} Peripheral Retinectomy
Lai et al.
Arch Ophthalmol 2002;120:1317-1324.
ABSTRACT | FULL TEXT  

Visual Outcomes in the Subfoveal Radiotherapy Study: A Randomized Controlled Trial of Teletherapy for Age-Related Macular Degeneration
Hart et al.
Arch Ophthalmol 2002;120:1029-1038.
ABSTRACT | FULL TEXT  

Decreased Visual Acuity Associated With Cystoid Macular Edema in Neovascular Age-related Macular Degeneration
Ting et al.
Arch Ophthalmol 2002;120:731-737.
ABSTRACT | FULL TEXT  

Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration
Haddad et al.
Br. J. Ophthalmol. 2002;86:663-669.
ABSTRACT | FULL TEXT  

Macular Translocation With 360{degrees} Retinotomy for Exudative Age-Related Macular Degeneration
Aisenbrey et al.
Arch Ophthalmol 2002;120:451-459.
ABSTRACT | FULL TEXT  

Quality of Life With Visual Acuity Loss From Diabetic Retinopathy and Age-Related Macular Degeneration
Brown et al.
Arch Ophthalmol 2002;120:481-484.
ABSTRACT | FULL TEXT  

Change in Full-Field ERGs after Macular Translocation Surgery with 360{degrees} Retinotomy
Terasaki et al.
IOVS 2002;43:452-457.
ABSTRACT | FULL TEXT  

Monoclonal Antibody-Mediated Drug Targeting to Choroidal Neovascularization in the Rat
Kamizuru et al.
IOVS 2001;42:2664-2672.
ABSTRACT | FULL TEXT  

Suppression of Choroidal Neovascularization by Adeno-associated Virus Vector Expressing Angiostatin
Lai et al.
IOVS 2001;42:2401-2407.
ABSTRACT | FULL TEXT  

Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy
Schnurrbusch et al.
Br. J. Ophthalmol. 2001;85:1086-1091.
ABSTRACT | FULL TEXT  

Age-Related Maculopathy in a Randomized Trial of Low-Dose Aspirin Among US Physicians
Christen et al.
Arch Ophthalmol 2001;119:1143-1149.
ABSTRACT | FULL TEXT  

Facilitation of Artificial Retinal Detachment for Macular Translocation Surgery Tested in Rabbit
Faude et al.
IOVS 2001;42:1328-1337.
ABSTRACT | FULL TEXT  

External Beam Irradiation of Subfoveal Choroidal Neovascularization Complicating Age-Related Macular Degeneration: One-Year Results of a Prospective, Double-Masked, Randomized Clinical Trial
Marcus et al.
Arch Ophthalmol 2001;119:171-180.
ABSTRACT | FULL TEXT  

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation
Newsom et al.
Br. J. Ophthalmol. 2001;85:173-178.
ABSTRACT | FULL TEXT  

A New Drug-Screening Procedure for Photosensitizing Agents Used in Photodynamic Therapy for CNV
Lange et al.
IOVS 2001;42:38-46.
ABSTRACT | FULL TEXT  

New Soft-Tipped Instruments for Foveal Translocation Surgery With 360{degrees} Retinotomy
Ohji et al.
Arch Ophthalmol 2000;118:1422-1424.
ABSTRACT | FULL TEXT  

Histological examination of the pigment epithelium-Bruch membrane-choriocapillaris complex after macular translocation
BERECZKI et al.
Br. J. Ophthalmol. 2000;84:546f-546.
FULL TEXT  

Foveal relocation by redistribution of the neurosensory retina
Wong and Lois
Br. J. Ophthalmol. 2000;84:352-357.
ABSTRACT | FULL TEXT  

Subretinal Surgery for Choroidal Neovascularization in Patients With High Myopia
Uemura and Thomas
Arch Ophthalmol 2000;118:344-350.
ABSTRACT | FULL TEXT  

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin: One-Year Results of 2 Randomized Clinical Trials--TAP Report 1
Treatment of Age-related Macular Degeneration With
Arch Ophthalmol 1999;117:1329-1345.
ABSTRACT | FULL TEXT  

Effects of Photodynamic Therapy Using Verteporfin on Experimental Choroidal Neovascularization and Normal Retina and Choroid up to 7 Weeks after Treatment
Husain et al.
IOVS 1999;40:2322-2331.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of a Single Treatment in a Phase 1 and 2 Study
Miller et al.
Arch Ophthalmol 1999;117:1161-1173.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of Retreatments in a Phase 1 and 2 Study
Schmidt-Erfurth et al.
Arch Ophthalmol 1999;117:1177-1187.
ABSTRACT | FULL TEXT  

Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration
Obana et al.
Br. J. Ophthalmol. 1999;83:429-437.
ABSTRACT | FULL TEXT  

Alternative therapies in exudative age related macular degeneration
CHONG and BIRD
Br. J. Ophthalmol. 1998;82:1441-1443.
FULL TEXT  

A Model of the Incidence and Consequences of Choroidal Neovascularization Secondary to Age-related Macular Degeneration: Comparative Effects of Current Treatment and Potential Prophylaxis on Visual Outcomes in High-Risk Patients
Lanchoney et al.
Arch Ophthalmol 1998;116:1045-1052.
ABSTRACT | FULL TEXT  

Correlation between Octopus perimetry and fluorescein angiography after strontium-90 plaque brachytherapy for subfoveal exudative age related macular degeneration
Jaakkola et al.
Br. J. Ophthalmol. 1998;82:763-768.
ABSTRACT | FULL TEXT  

Scanning laser fundus perimetry before laser photocoagulation of well defined choroidal neovascularisation
Rohrschneider et al.
Br. J. Ophthalmol. 1997;81:568-573.
ABSTRACT | FULL TEXT  

Recent Advances: Ophthalmology
Towler and Lightman
BMJ 1996;312:889-892.
ABSTRACT | FULL TEXT  

Diseases of the Retina
D'Amico
NEJM 1994;331:95-106.
FULL TEXT